(GDRX) GoodRx Holdings, Inc. Business Model Canvas Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(GDRX) GoodRx Holdings, Inc. Complete Analysis Pack
GoodRx Business Model Canvas: How Its Savings Platform Creates Value
Unlock the full Business Model Canvas for GoodRx Holdings, Inc. and see how its prescription savings platform creates value across customers, pharmacies, and healthcare partners. This concise, company-specific breakdown highlights revenue streams, key activities, and strategic advantages in a fast-changing market. Ideal for investors, analysts, and founders—download the full version for deeper insight.
Partnerships
Pharmacy benefit managers
GoodRx partners with PBMs to pull negotiated prescription rates and turn them into the discount codes users see on the platform. These links also support price discovery and pharmacy claim processing across a network of more than 70,000 U.S. pharmacies, which is central to GoodRx's transaction flow.
Retail pharmacy networks
Retail pharmacy networks are GoodRx Holdings, Inc.’s key execution partners: consumers present GoodRx codes at the point of sale, and participating pharmacies process the discount in real time. GoodRx says its coupons are accepted at more than 70,000 U.S. pharmacy locations, which gives the coupon model national reach.
This partner base turns pharmacy counters into the last mile for savings, helping GoodRx scale without owning stores.
Pharmaceutical manufacturers
Pharmaceutical manufacturers use GoodRx to reach millions of patients with affordability support, which helps move branded medicines and keep people on therapy. This channel also feeds GoodRx's manufacturer solutions revenue; in 2025, that business remained a core revenue stream alongside the company's pharmacy and consumer offers.
Telehealth providers and clinicians
GoodRx Holdings, Inc. relies on telehealth providers and clinicians to power virtual visits and prescription fulfillment, so the platform is not just a price-check tool. These partners widen access to care and help turn GoodRx into a care-entry point, not only a savings app.
- Enables virtual care
- Supports e-prescribing flow
- Extends access beyond pricing
Technology and advertising partners
GoodRx relies on search, paid media, and app-distribution partners to bring consumers to its platform, and those channels sit at the center of user acquisition and monetization. The company’s latest filings show that digital traffic and marketing partners remain key to scaling its consumer base and driving prescription savings activity.
- Search drives consumer traffic.
- Media partners support acquisition.
- Data partners improve monetization.
GoodRx’s Partner Network Powers Its Prescription Savings Engine
GoodRx Holdings, Inc. depends on PBMs, pharmacy networks, manufacturers, telehealth providers, and digital traffic partners to source discounts, process claims, and bring users to the platform. Its coupon network reaches more than 70,000 U.S. pharmacy locations, and manufacturer solutions stayed a core revenue stream in 2025.
These partners let GoodRx scale savings and virtual care without owning pharmacies or clinics. The model works because each partner supports a different step in the prescription flow.
| Partner | Role | Data |
|---|---|---|
| PBMs | Supply negotiated rates | Core to pricing flow |
| Pharmacies | Accept discount codes | 70,000+ locations |
| Manufacturers | Support affordability | Core revenue in 2025 |
What is included in the product
Detailed Word Document
A concise Business Model Canvas of GoodRx Holdings, Inc. showing how it connects consumers, pharmacies, and healthcare partners through digital prescription savings.
Customizable Excel Spreadsheet
Quickly spot how GoodRx eases prescription cost pain points in a concise, editable business model snapshot.
Reference Sources
Helps validate GoodRx assumptions fast by linking each key claim to credible, traceable sources for stronger diligence and decision-making.
Activities
Prescription price comparison
GoodRx’s core activity is prescription price comparison: it aggregates prices across pharmacies, locations, and insurance or cash-pay plans, then shows lower-cost options by geography. The platform reaches over 30 million consumers, making pricing search the main driver of its consumer business.
Discount code management
GoodRx Holdings, Inc. issues GoodRx codes that users can present at more than 70,000 U.S. pharmacies to capture negotiated drug discounts. Keeping each code accurate, usable, and synced with pharmacy pricing is a daily task that protects conversion and trust.
This code layer supports a low-friction shopping flow for prescriptions, which is central to GoodRx Holdings, Inc. in 2025.
Platform and app operation
GoodRx runs a web and mobile platform that has to keep prescription price search, coupon delivery, and user flows accurate and fast. Product updates matter because better search and smoother app use directly support repeat visits and retention.
Manufacturer program execution
GoodRx’s manufacturer program execution is a core B2B engine: it runs programs for pharmaceutical manufacturers that improve patient access, raise drug awareness, and lower out-of-pocket costs at the pharmacy counter. This sits beside consumer subscriptions and savings tools, and it helps GoodRx convert manufacturer demand into measurable reach across its prescription network.
- Supports access, awareness, savings
- Core B2B revenue driver
- Links manufacturers to patients
Telehealth service delivery
GoodRx’s telehealth service delivery links patients to care on its platform, so the key work is scheduling, clinical coordination, and digital visit flow. This matters because the company’s 2024 10-K shows $792.9 million in revenue, and telehealth helps extend that prescription-focused funnel into a faster care-to-pharmacy path.
- Schedules visits inside the app
- Coordinates clinicians and workflows
- Connects care to prescriptions
GoodRx Powers 30M+ Savings Across 70,000+ Pharmacies
GoodRx Holdings, Inc. turns prescription search, coupon delivery, and pharmacy routing into its core work: keep prices current, keep GoodRx codes working at 70,000+ U.S. pharmacies, and keep the app fast for 30 million+ consumers. It also runs manufacturer programs and telehealth flows that link patient access to the pharmacy counter.
| Key activity | Scale |
|---|---|
| Consumer savings platform | 30M+ users |
| Pharmacy code network | 70,000+ pharmacies |
| Revenue | $792.9M |
Delivered as Displayed
Business Model Canvas
This preview shows a real section of the GoodRx Holdings, Inc. Business Model Canvas you’ll receive after purchase. It is not a sample or mockup—the same professionally formatted document will be delivered in full. What you see here is exactly what you’ll download, ready to edit, present, or share.
Resources
Digital prescription platform
GoodRx Holdings, Inc.’s digital prescription platform is the key resource: its website and app connect users to drug prices, discounts, and telehealth, and in 2025 the business still relied on this digital layer to reach millions of consumers at scale. Without that platform, GoodRx cannot route demand, capture prescriptions, or monetize traffic efficiently.
Prescription pricing database
GoodRx Holdings, Inc. depends on a live prescription pricing database to show current cash prices, savings offers, and coupons by pharmacy and ZIP code. Fresh data is key to user trust, because even small price gaps can change the best option at the counter and hurt conversion if the match is stale.
Brand and consumer audience
GoodRx’s brand is tightly linked to prescription savings, and its platform reached over 20 million consumers in 2024. That scale drives traffic, supports monetization, and lowers customer acquisition friction because many users already know the name before they need a coupon or telehealth service.
Partner contracts and network access
Partner contracts with PBMs, pharmacies, and manufacturers are GoodRx Holdings, Inc.’s key resource because they unlock negotiated rates and program access that competitors can’t copy fast. The moat is the network itself: once these agreements are in place, they support price comparison, discount fulfillment, and manufacturer-funded savings at scale.
- PBM contracts drive negotiated pricing.
- Pharmacy access enables prescription fill flow.
- Manufacturer deals fund savings programs.
- Hard to replicate quickly.
Data, analytics, and technology talent
GoodRx Holdings, Inc. depends on data, analytics, and technology talent to run pricing tools, personalization, and digital product performance. These teams support both consumer services and B2B offerings, so engineering speed and data quality directly affect user trust and revenue execution.
- Engineering keeps pricing tools live
- Analytics improves personalization and conversion
- Product teams support consumer and B2B growth
GoodRx’s Core Resources Power Scale, Savings, and Speed
In 2025, GoodRx Holdings, Inc.’s key resources were its digital platform, live pricing data, and partner network. Its reach across 20 million+ consumers and access to about 70,000 U.S. pharmacies made price search and coupon use fast at scale.
PBM, pharmacy, and manufacturer contracts are the other core asset, because they power negotiated savings and program access. The company also needs strong data and engineering talent to keep prices current and conversion high.
| Key resource | Why it matters | Data point |
|---|---|---|
| Digital platform | Routes demand and monetizes traffic | 20 million+ consumers |
| Pharmacy network | Enables coupon use and fills | About 70,000 pharmacies |
Value Propositions
Lower prescription drug costs
GoodRx’s core promise is simple: lower out-of-pocket drug costs for consumers. The platform is built around savings and affordability, and GoodRx says it has helped users save more than $85 billion on prescription spending since launch. In fiscal 2024, GoodRx reported $794 million in revenue, showing that price transparency and discount access remain its main value driver.
Localized price comparison
GoodRx Holdings, Inc. shows prescription prices by ZIP code, so users can compare local cash prices before they fill. That point-of-need pricing helps shoppers pick the lower-cost pharmacy in their area and is central to GoodRx’s reach across millions of U.S. prescription searches each year.
Nationwide discount access
GoodRx codes work at over 70,000 U.S. pharmacies, giving consumers broad nationwide access without needing insurance for many discounts. That reach helps make prescription savings more usable for uninsured and underinsured patients, which supports GoodRx Holdings, Inc.'s large-scale accessibility model.
Subscription-based savings
GoodRx Holdings, Inc. sells paid subscriptions, like GoodRx Gold, to give frequent users deeper drug savings than free coupons alone. These plans add sticky, recurring revenue: in recent filings, GoodRx has still relied on subscription and other service revenue to support a business that served millions of monthly users.
- Deeper savings for repeat medication users
- Recurring revenue from paid plans
- Supports higher customer retention
Telehealth and manufacturer support
GoodRx Holdings, Inc. pairs prescription savings with telehealth and manufacturer support, so users can compare prices, see a clinician, and tap copay or patient-assistance programs in one place. That broadens the offer beyond coupons and helps move users from price shopping to treatment access.
- One platform for savings and care
- Telehealth adds treatment access
- Manufacturer programs widen coverage
GoodRx: Making Prescription Savings Visible at Scale
GoodRx Holdings, Inc. makes prescription costs visible and lower at the point of sale, with cash-price comparisons by ZIP code and coupons accepted at over 70,000 pharmacies. Its savings story is real scale too: GoodRx says users have saved more than $85 billion since launch, and fiscal 2024 revenue was $794 million.
| Value proposition | Data point |
|---|---|
| Prescription savings | $85B+ saved since launch |
| Access | 70,000+ pharmacies |
| Scale | $794M revenue in fiscal 2024 |
Customer Relationships
Self-service digital access
GoodRx Holdings, Inc. relies on self-service digital access, so most users search drug prices on the website or app without a sales agent. The flow is built for fast price checks and quick pharmacy comparisons, which keeps service low-friction and scalable.
Personalized recommendations
GoodRx tailors pricing and savings by ZIP code and medication, so users see the most relevant pharmacy options fast. Its price network spans 70,000+ U.S. pharmacies, and that kind of local fit improves engagement and keeps people coming back when they need another fill.
Subscription membership support
GoodRx’s subscription membership support keeps paying users tied to ongoing savings, which helps retention because members renew to keep access to discounted drug prices. In FY2024, GoodRx reported about $799 million in revenue, showing how recurring user relationships can support steady monetization, while renewal help and account support reduce churn.
Telehealth care interactions
Telehealth care interactions make GoodRx Holdings, Inc. more hands-on: users move from price checks into appointments, follow-ups, and prescription steps, so support needs rise across the care flow. That pushes the relationship from transaction-based to service-based, with care navigation and refill help becoming part of the product.
- Direct care workflow, not just discounts
- Needs appointment and follow-up support
- Prescription steps deepen service ties
B2B account management
GoodRx Holdings, Inc. relies on B2B account management to keep manufacturer and partner clients aligned on program design, reporting, and campaign execution. In FY2025, this consultative layer mattered because partner work is managed, not self-serve, and it directly supports revenue tied to branded, recurring relationships.
- Structured client support
- Program and report management
- Campaign execution oversight
- Consultative, not self-service
GoodRx Scales Digital Pharmacy Access Across 70,000+ Locations
GoodRx Holdings, Inc. keeps customer ties mostly digital and self-serve, so users can check prices and compare pharmacies fast. Its subscription and telehealth flows deepen the relationship by adding renewal help, care navigation, and prescription support.
The model scales because the network covers 70,000+ U.S. pharmacies, and FY2024 revenue was about $799 million, showing repeat use can support monetization.
| Metric | Value |
|---|---|
| U.S. pharmacies | 70,000+ |
| FY2024 revenue | $799 million |
Channels
Website platform
GoodRx Holdings, Inc.’s website platform is the main entry point for price comparison and savings codes, serving both first-time and returning users. Search visibility is a key traffic engine, so organic discovery directly supports user acquisition and repeat use across the GoodRx site.
Mobile application
GoodRx Holdings, Inc.'s mobile app lets users search drug prices and pull up savings at the pharmacy counter, which is where the decision gets made. In 2024, GoodRx said it served about 6 million monthly active consumers, showing how mobile use supports repeat engagement and keeps users coming back.
Search and online discovery
Consumers often reach GoodRx through internet search, so this channel captures high-intent shoppers looking for drug prices and coupons right when they need them. Organic and paid search stay core acquisition routes, and GoodRx’s latest public filings show the model still depends on digital traffic to drive consumer engagement and pharmacy savings.
Email and push notifications
Email and push notifications let GoodRx Holdings, Inc. send savings alerts, refill reminders, and subscription updates directly to users, which helps drive repeat visits and retention. These low-cost messages support recurring use for paid plans and price-drop alerts, which is important because GoodRx monetized 2025 with 3 main lines: Consumer, Pharma Manufacturer Solutions, and Subscription.
- Drives repeat usage
- Supports subscriptions
- Sends savings updates
- Keeps users engaged
Pharmacy point-of-sale use
GoodRx codes are scanned directly at the pharmacy counter, making the store the last step in the discount journey. GoodRx says its coupons work at more than 70,000 U.S. pharmacies, so the channel turns online price search into immediate in-store savings and completed fills.
Final fulfillment happens at checkout.
Links digital demand to pharmacy savings.
Uses a wide U.S. pharmacy network.
GoodRx’s Digital Reach: 6M Users, 70,000+ Pharmacies
GoodRx Holdings, Inc. channels are mostly digital: web search, the mobile app, email/push alerts, and pharmacy checkout. In 2025, GoodRx reported about 6 million monthly active consumers and access to more than 70,000 U.S. pharmacies, so traffic can turn into savings fast.
| Channel | Role | Scale |
|---|---|---|
| Website | Price search | Main entry point |
| App | Counter use | 6M MAUs |
| Pharmacies | Fulfillment | 70,000+ |
Customer Segments
Uninsured consumers
Uninsured consumers are a core mass-market segment for GoodRx Holdings, Inc. They often need direct prescription savings when insurance won’t cover a drug, and GoodRx’s 70,000+ pharmacy network makes price checks and coupons useful at the point of sale. With roughly 25 million uninsured people in the U.S., this remains a large, recurring need.
Underinsured and high-deductible patients
Roughly 1 in 4 insured U.S. adults are underinsured, so many still face high out-of-pocket drug costs. GoodRx helps these patients compare cash prices and discounts, and they use it when the pharmacy cash price is lower than the insurance copay or deductible.
Frequent prescription users
Frequent prescription users are a core GoodRx Holdings, Inc. segment because recurring meds create repeat app use and higher lifetime value. With about 66% of U.S. adults using at least one prescription drug, subscription savings matter for chronic users, and GoodRx’s 2024 revenue of $792 million shows how retention-linked refill behavior supports the model.
Caregivers and family medication shoppers
Caregivers and family medication shoppers often compare prices for more than one person, so they need fast, plain savings tools. GoodRx fits that behavior with multi-drug searches and pharmacy comparison, helping price-sensitive users navigate a U.S. market where 53 million adults provided unpaid care in 2020, a large base for repeat prescription shopping.
- Fast search for multiple medicines
- Simple price comparisons by pharmacy
- Built for caregivers buying for others
Pharmaceutical manufacturers and healthcare partners
GoodRx also sells to pharmaceutical manufacturers and healthcare partners through manufacturer programs and related services, so this is a separate B2B revenue stream from consumer subscriptions and prescription savings. These clients use GoodRx to reach patients, support access, and improve fill rates, which makes the segment a direct monetization layer inside the platform.
- B2B revenue from manufacturer programs
- Helps reach patients at scale
- Supports access and adherence
GoodRx: Cutting Rx Costs for Consumers and Expanding Access for B2B
GoodRx Holdings, Inc. serves uninsured and underinsured consumers, plus frequent refill users and caregivers who compare drug prices across pharmacies. Its B2B buyers include pharmaceutical manufacturers and healthcare partners; in 2024 GoodRx reported $792 million revenue and reached 70,000+ pharmacies.
| Segment | Need |
|---|---|
| Consumer | Lower Rx cost |
| B2B | Patient access |
Cost Structure
Technology development costs
GoodRx’s technology development cost sits in engineering, product, and platform upkeep, and it is mostly a fixed operating cost. The app and website need constant updates, security patches, and uptime support, so this spend stays high even when usage shifts.
In its latest annual filing, GoodRx reported roughly $800 million in annual revenue, which shows how central the digital platform is to the model. That means core tech infrastructure is not optional; it is the base that keeps prescription search, coupons, and partner links working.
Sales and marketing spend
GoodRx Holdings, Inc. relies on digital acquisition, so sales and marketing spend goes into search ads, media, and promotions that drive traffic and conversions. These costs are material because GoodRx’s business model depends on keeping user acquisition efficient and maintaining strong brand visibility.
Personnel and corporate overhead
GoodRx Holdings, Inc. carries a lean but broad staffing base across product, operations, compliance, finance, and customer support, and those costs sit inside SG&A rather than direct cost of revenue. As a public company, it also pays for legal, audit, investor relations, and headquarters administration, so personnel and overhead remain a core fixed-cost layer in 2025.
Data and partner access costs
GoodRx Holdings, Inc. must pay to keep drug-price data current and pharmacy partner links live, and those service, access, and transaction fees sit at the core of the model. In 2024, the Company generated about $800 million in revenue, so even small data errors can hurt trust, traffic, and margin.
- Keep pricing data accurate
- Fund pharmacy integrations
- Pay access and transaction fees
Clinical and telehealth operating costs
GoodRx Holdings, Inc. bears clinical and telehealth operating costs for licensed providers, care workflows, and HIPAA-grade security, so each visit adds variable expense. These costs rise with service usage, making telehealth margin-sensitive when demand spikes.
That cost base also covers scheduling, charting, e-prescribing, and platform monitoring, so higher visit volume can lift revenue but also raise fulfillment and compliance spend at the same time.
- Provider fees scale with each visit
- Secure care delivery adds tech spend
- Compliance costs rise with usage
GoodRx’s Margin Moves Fast on Traffic, Fees, and Uptime
GoodRx Holdings, Inc. keeps most cost in fixed tech, SG&A, and marketing, while data, pharmacy links, and telehealth add variable spend. With about $800 million in annual revenue in the latest filing, even small gains or slips in traffic, uptime, or partner fees can move margin fast.
| Cost item | Driver |
|---|---|
| Platform tech | Fixed upkeep |
| Marketing | Traffic growth |
| Data and partner fees | Usage-linked |
Revenue Streams
Consumer subscription fees
GoodRx Holdings, Inc. charges users for subscription products, turning frequent prescription-saving use into recurring revenue. In the latest public filings, these paid plans help stabilize sales by monetizing repeat savings behavior, alongside GoodRx’s broader annual revenue base of about $800 million.
Pharmaceutical manufacturer program fees
Pharmaceutical manufacturer program fees are a core B2B stream for GoodRx Holdings, Inc., with drug makers paying for programs that improve patient access and support brand visibility. GoodRx reported $798.0 million of revenue in 2024, and this fee model helps diversify income beyond consumer transactions and price-shopping traffic.
Telehealth service revenue
Telehealth visits and related services add a paid care layer on top of GoodRx Holdings, Inc.’s pharmacy platform, so revenue grows beyond drug savings. This boosts platform use by turning search and price tools into a care entry point, with earnings tied to each visit, follow-up, and service bundle.
Advertising and sponsored placements
GoodRx Holdings, Inc. monetizes its large consumer traffic through advertising and sponsored placements, turning pharmacy and drug-search intent into paid visibility for brands. The model scales with audience reach: GoodRx reported about $800 million in annual revenue, while its platform drew tens of millions of consumers, giving advertisers a focused health-care audience.
- Earns from paid promo placements
- Uses high-intent user traffic
- Backed by a large consumer base
Platform and data-related partner revenue
GoodRx monetizes partner access, program administration, and data services on top of its prescription network, which spans 70,000+ U.S. pharmacies. In FY2025, this model sat inside a business that generated roughly $0.8 billion in annual revenue, showing how its infrastructure turns traffic and prescription data into partner fees.
- Partner access fees
- Program admin services
- Data and analytics revenue
GoodRx’s Revenue Engine: Subscriptions, Fees, Telehealth, and Ads
GoodRx Holdings, Inc. earns mainly from consumer subscriptions, manufacturer program fees, telehealth visits, and paid ads/sponsored placements. FY2025 revenue was about $0.8 billion, supported by 70,000+ U.S. pharmacy network reach and high-intent prescription traffic.
| Stream | FY2025 |
|---|---|
| Subscriptions | Recurring |
| Manufacturer fees | Core B2B |
| Telehealth | Per visit |
| Ads | Sponsored |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.